These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 1082678)

  • 21. [Diagnosis and treatment of obstetric thrombohemorrhagic syndrome].
    Grigorian AA; Avanesian RM; Melkonian VK
    Zh Eksp Klin Med; 1974; 14(4):96-103. PubMed ID: 4547478
    [No Abstract]   [Full Text] [Related]  

  • 22. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
    Stein SF; Harker LA
    J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Enzymic and non-enzymic fibrinolysis during intravenous administration of trypsin].
    Umarova BA; Strukova SM; Kudriashov BA
    Vopr Med Khim; 1984; 30(2):95-100. PubMed ID: 6540008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
    Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Formation of a secondary adrenaline-heparin-fibrinogen complex and its properties].
    Kudriashov BA; Liapina LA; Zhitnikova ES; Obraztsov VV
    Vopr Med Khim; 1975; 21(1):65-9. PubMed ID: 1119113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
    Bremme K; Lind H; Blombäck M
    Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Electron microscopic study of the molecular forms of products of unstabilized fibrin dissolution by complex compounds of heparin].
    Kudriashov BA; Ul'ianov AM; Zhitnikova ES
    Dokl Akad Nauk SSSR; 1977; 237(4):965-8. PubMed ID: 590080
    [No Abstract]   [Full Text] [Related]  

  • 30. [The role of adrenaline and ACTH in the process of complex heparin compound formation in the blood during imobilization stress].
    Kudriashov BA; Shapiro FB; Lomovskaia EG; Liapina LA
    Probl Endokrinol (Mosk); 1975; 21(5):54-9. PubMed ID: 180515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ; Joist JH
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute fibrinopenia in obstetrics].
    Torrielli R; Boutin F; Rochet M; Neophytou P; Lahaye F
    Rev Fr Gynecol Obstet; 1988; 83(7-9):509-13. PubMed ID: 3264078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The role of the antithrombin III-heparin-thrombin complex in the defense reaction of the anticoagulation system].
    Kudriashov BA; Liapina LA; Pastorova VE
    Vopr Med Khim; 1988; 34(2):38-42. PubMed ID: 3400189
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A reconstituted dilute blood clot lysis assay for the medium throughput screening of thrombolytic compounds.
    Gadbut AP; Schullek JR; Hanel AM; MacAllan DR
    Anal Biochem; 1999 May; 270(1):24-32. PubMed ID: 10328761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Value of determining complex heparin compounds for early diagnosis and evaluation of the degree of severity of late pregnancy toxemia].
    Zakharova TP
    Akush Ginekol (Mosk); 1986 Apr; (4):57-9. PubMed ID: 2940925
    [No Abstract]   [Full Text] [Related]  

  • 36. Fibrin clot lysis by thrombolytic agents is impaired in newborns due to a low plasminogen concentration.
    Andrew M; Brooker L; Leaker M; Paes B; Weitz J
    Thromb Haemost; 1992 Sep; 68(3):325-30. PubMed ID: 1440499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measurement of fibrinopeptide A in the evaluation of heparin activity and fibrin formation during hemodialysis.
    Wilhelmsson S; Asaba H; Gunnarsson B; Kudryk B; Robinson D; Bergström J
    Clin Nephrol; 1981 May; 15(5):252-8. PubMed ID: 7249422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of three different heparin regimes on heparin concentrations in plasma and fibrin formation in dialyzers.
    Gunnarsson B; Asaba H; Dawidson S; Wilhelmsson S; Bergström J
    Clin Nephrol; 1981 Mar; 15(3):135-42. PubMed ID: 7273488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots.
    Sangrar W; Koschinsky ML
    Biochem Cell Biol; 2000; 78(4):519-25. PubMed ID: 11012092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrinogen and fibrin structure and functions.
    Mosesson MW
    J Thromb Haemost; 2005 Aug; 3(8):1894-904. PubMed ID: 16102057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.